Product class:
|
Medicinal product with marketing authorization
|
Medicinal product class:
|
Veterinary medicine
|
Name of medicinal product:
|
Hemosilate vet
|
Active substances:
|
|
ATC code:
|
QB02BX01
|
Dosage form:
|
solution for injection
|
Strength:
|
125mg 1ml
|
Legal status for supply*:
|
Subject to medicinal prescription
|
Summary of product characteristics (SPC):
|
(last updated June 6, 2023)
|
Package information leaflet (PIL):
|
EST (last updated June 6, 2023)
|
Labelling:
|
(last updated June 6, 2023)
|
Indication:
|
Prevention and treatment of surgical, post traumatic, obstetric and gynecological haemorrhages.
|
Safety features:
|
No
|
Marketing authorization holder:
|
Ecuphar Veterinaria S.L.U.
|
Marketing authorization number:
|
2226
|
Marketing authorization issued on:
|
February 5, 2020
|
Marketing authorization expires on:
|
Unlimited
|
Marketing authorization procedure type:
|
Mutual recognition
|
Assessment report:
|
|
Package code
|
Name of medicinal product
|
Dosage form
|
Package
|
Legal status
|
Reimbursements
|
Reference price
|
Last imported
|
PƤritolumaa
|
Additional information
|
1788037
|
Hemosilate vet
|
solution for injection
|
125mg 1ml 20ml 1TK
|
Prescription
|
|
|
|
|
|
1788048
|
Hemosilate vet
|
solution for injection
|
125mg 1ml 20ml 5TK
|
Prescription
|
|
|
24.01.2023
|
|
|
1788059
|
Hemosilate vet
|
solution for injection
|
125mg 1ml 20ml 10TK
|
Prescription
|
|
|
|
|
|
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere